Couragene believes that delivery of gene and biologic therapies should be safer and more efficient. Delivery of genome modification therapies to brain is further complicated by the physiological barriers. Couragene's STEP (Stimuli-responsive Traceless Engineering Platform) technology has demonstrated great potential to overcome the delivery hurdles for treatment of various diseases, including neurogenetic disorders.
Company Details
- Employees
- 4
- Founded
- 2022
- Address
- 675 Us Highway 1, North Brunswick,new Jersey 08902,united States
- Industry
- Biotechnology
- Website
- https://www.couragene.com/
- Keywords
- Non-viral gene therapy, CRISPR, Oral drug delivery, genome editing, DNA/RNA delivery, ASO delivery, gene disruption, epigenetic regulation, neurogenetic diseases, rare disease.
- HQ
- North Brunswick, New Jersey
Couragene Questions
Couragene's website is https://www.couragene.com/
Couragene's LinkedIn profile is https://www.linkedin.com/company/couragene
Couragene has
4 employees.
View email and phone details for 4
employees at Couragene.
Couragene's industry is
Biotechnology
Couragene's categories are Biotechnology
Couragene's founding year is 2022
